Long noncoding RNAs (lncRNAs) play vital roles in tumorigenesis. However, the diagnostic values of most lncRNAs are largely unknown. To investigate whether gastric juice lncRNA-ABHD11-AS1 can be a potential biomarker in the screening of gastric cancer, 173 tissue samples and 130 gastric juice from benign lesion, gastric dysplasia, gastric premalignant lesions, and gastric cancer were collected. ABHD11-AS1 levels were detected by reverse transcription-polymerase chain reaction. Then, the relationships between ABHD11-AS1 levels and clinicopathological factors of patients with gastric cancer were investigated. The results showed that ABHD11-AS1 levels in gastric cancer tissues were significantly higher than those in other tissues. Its levels in gastric juice from gastric cancer patients were not only significantly higher than those from cases of normal mucosa or minimal gastritis, atrophic gastritis, and gastric ulcers but also associated with gender, tumor size, tumor stage, Lauren type, and blood carcinoembryonic antigen (CEA) levels. More importantly, when using gastric juice ABHD11-AS1 as a marker, the positive detection rate of early gastric cancer patients was reached to 71.4 %. Thanks to the special origin of gastric juice, these results indicate that gastric juice ABHD11-AS1 may be a potential biomarker in the screening of gastric cancer.
ABHD11-AS1 Gastric cancer Gastric juice Gene diagnosis Long noncoding RNA Tumor marker
This is a preview of subscription content, log in to check access.
This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. LY14C060003), the Applied Research Project on Nonprofit Technology of Zhejiang Province (No. 2014C33222), the National Natural Science Foundation of China (No. 81171660), and the K. C. Wong Magna Fund in Ningbo University.
Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K. Methylation-mediated gene silencing as biomarkers of gastric cancer. World J Gastroenterol. 2014;20:11991–2006.CrossRefPubMedPubMedCentralGoogle Scholar
Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, et al. LncRNA-AC13710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol. 2014;35:9701–6.CrossRefPubMedGoogle Scholar
Lin X, Yang M, Xia T, Guo J. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance. Med Oncol. 2014;31:42.CrossRefPubMedGoogle Scholar
Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013;119:1618–26.CrossRefPubMedGoogle Scholar
Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;20:3320–8.CrossRefGoogle Scholar
Sobin LH, Compton CC. TNM seventh edition: what’s new, what’s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 2010;116:5336–9.CrossRefPubMedGoogle Scholar
Mei D, Song H, Wang K, Lou Y, Sun W, Liu Z, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.CrossRefPubMedGoogle Scholar
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, et al. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2013;139:437–45.CrossRefPubMedGoogle Scholar
Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J. Clinical significance of low expression of FER1L4 in gastric cancer patients. Tumour Biol. 2014;35:9613–7.CrossRefPubMedGoogle Scholar
Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M, et al. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014;35:9591–5.CrossRefPubMedGoogle Scholar
Zhang X, Cui L, Ye G, Zhang T, Song H, Xia T, et al. Gastric juice microRNA-421 is a new biomarker for screening cancer. Tumour Biol. 2012;33:2349–55.CrossRefPubMedGoogle Scholar
Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol. 1997;4:137–40.CrossRefPubMedGoogle Scholar
Sugita H, Kojima K, Inokuchi M, Kato K. Long-term outcomes of laparoscopic gastrectomy for gastric cancer. J Surg Res. 2015;193:190–5.CrossRefPubMedGoogle Scholar
Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg. 2002;26:1160–5.CrossRefPubMedGoogle Scholar
Tian S, Yu J, Kang W, Ma Z, Ye X, Cao Z, et al. Combined detection of CEA, CA 19–9, CA242 and CA50 in the diagnosis and prognosis of resectable gastric cancer. Asian Pac J Cancer Prev. 2014;15:6295–300.CrossRefPubMedGoogle Scholar
Koessler T, Roth A, Cacheux W. Early gastric cancer: epidemiology, diagnostic, and management. Rev Med Suisse. 2014;10:1118–22.PubMedGoogle Scholar